WASHINGTON, Sept 21 (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc PFE.N could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson JNJ.N could come later.
Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later." He also cited efforts by Moderna Inc MRNA.O and AstraZeneca Plc AZN.L.
(Reporting by Susan Heavey)
((email@example.com; +1 202 843 6600;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.